STOCK TITAN

Enlivex Ltd. (ENLV) Stock News, Jun 2023-Feb 2024

ENLV NASDAQ

Enlivex Ltd. develops quality longevity therapeutics and operates a prediction markets treasury alongside its clinical programs. The company’s news centers on Allocetra™, a clinical-stage immunotherapy for inflammatory conditions associated with aging, with a primary focus on moderate-to-severe age-related knee osteoarthritis.

Recurring updates also cover the RAIN token and Rain protocol, including digital asset treasury holdings, exchange listings, decentralized prediction-market infrastructure, tokenized exposure to Enlivex ordinary shares, financial results affected by treasury assets, financing activity, and share repurchase authorization.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.53%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.10%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.96%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.73%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
conferences
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.81%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags

FAQ

What is the current stock price of Enlivex (ENLV)?

Enlivex (ENLV) last closed at $1.19.

What is the market cap of Enlivex (ENLV)?

The market cap of Enlivex (ENLV) is approximately $1.8M.